UB Paderborn / Katalog / Suche / in CDI

Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2019-09, Vol.31 (9), p.611-620

2019

Volltextzugriff (PDF)

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity

Clinical oncology (Royal College of Radiologists (Great Britain)), 2019-09, Vol.31 (9), p.600-610

2019

Volltextzugriff (PDF)

Provision of Organ at Risk Contouring Guidance in UK Radiotherapy Clinical Trials

Clinical oncology (Royal College of Radiologists (Great Britain)), 2020-02, Vol.32 (2), p.e60-e66

2020

Volltextzugriff (PDF)

8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group

European journal of cancer (1990), 2015-09, Vol.51, p.S712-S712

2015

Volltextzugriff (PDF)

1573 poster A DOSIMETRY COMPARISON OF FORWARD- AND INVERSE-PLANNED IMRT FOR PROSTATE CANCER IN THE CHHIP TRIAL

Radiotherapy and oncology, 2011, Vol.99, p.S585-S585

2011

Volltextzugriff (PDF)

1575 poster A SURVEY OF THE BENEFITS TO RT PROCESSES AND TECHNIQUES OF PARTICIPATING IN THE CHHIP TRIAL

Radiotherapy and oncology, 2011, Vol.99, p.S585-S585

2011

Volltextzugriff (PDF)

PO-0877 STREAMLINING UK IMRT CREDENTIALING: IMRT PLAN COMPLEXITY HIERARCHY

Radiotherapy and oncology, 2012-05, Vol.103, p.S343-S344

2012

Volltextzugriff (PDF)

OC-0154: IGRT for prostate cancer ñ results from the CHHiP IGRT phase II sub-study

Radiotherapy and oncology, 2014, Vol.111, p.S59-S59

2014

Volltextzugriff (PDF)

PO-1800: Successful Implementation of Treatment Planning Trial QA for the PIVOTALboost Trial

Radiotherapy and oncology, 2020-11, Vol.152, p.S1004-S1005

2020

Volltextzugriff (PDF)

395 poster A REVIEW OF IMRT CREDENTIALING FOR CLINICAL TRIALS IN THE UK

Radiotherapy and oncology, 2011, Vol.99, p.S156-S156

2011

Volltextzugriff (PDF)

OC-0421 Development and QA of IGRT procedures for node-positive prostate cancer patients in the PEARLS trial

Radiotherapy and oncology, 2023-05, Vol.182, p.S323-S324

2023

Volltextzugriff (PDF)

A Comparison of Treatment Planning Techniques Used in Two Randomised UK External Beam Radiotherapy Trials for Localised Prostate Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2008-02, Vol.20 (1), p.15-21

2008

Volltextzugriff (PDF)

Variability Analysis of Clinical Target Volume Outlining for Prostate Stereotactic Body Radiotherapy within the Multicentre PACE Trial

Clinical oncology (Royal College of Radiologists (Great Britain)), 2019-02, Vol.31 (2), p.e23-e23

2019

Volltextzugriff (PDF)

1577 poster A UK-WIDE QUALITY ASSURANCE PROGRAMME FOR AN IMAGE-GUIDED RADIOTHERAPY PROSTATE TRIAL

Radiotherapy and oncology, 2011, Vol.99, p.S586-S586

2011

Volltextzugriff (PDF)

PH-0602: Dosimetric impact of central OAR review on rectal and bladder constraint attainment in PACE-B trial

Radiotherapy and oncology, 2020-11, Vol.152, p.S339-S340

2020

Volltextzugriff (PDF)

PD-0758 Fraction Size Sensitivity (α/β ratios) For Late Genitourinary Toxicities After Prostate EBRT

Radiotherapy and oncology, 2021-08, Vol.161, p.S589-S590

2021

Volltextzugriff (PDF)

5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated External Beam Radiotherapy for Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2023-11, Vol.117 (4), p.e2-e3

2023

Volltextzugriff (PDF)

PO-1348: Can reference data for TPS beam parameters be used to create a good quality dose calculation model?

Radiotherapy and oncology, 2020-11, Vol.152, p.S714-S714

2020

Volltextzugriff (PDF)

OC-0289 Comparison of side effects at 2 years in the randomised PACE-B trial (SBRT vs standard radiotherapy)

Radiotherapy and oncology, 2021-08, Vol.161, p.S196-S197

2021

Volltextzugriff (PDF)

OC-0421: Consistency of organs at risk delineation guidance in UK radiotherapy clinical trials

Radiotherapy and oncology, 2018-04, Vol.127, p.S220-S220

2018

Volltextzugriff (PDF)

Patient Reported Acute Toxicity in PACE-B, an International Phase III Randomised Controlled Trial Comparing Stereotactic Body Radiotherapy to Conventionally Fractionated or Moderately Hypofractionated Radiotherapy (CFMHRT) for Localised Prostate Cancer

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.S55-S56

2019

Volltextzugriff (PDF)

A Database of Neutron Spectra, Instrument Response Functions, and Dosimetric Conversion Factors for Radiation Protection Applications

Radiation protection dosimetry, 1997-04, Vol.70 (1-4), p.241-245

1997

Volltextzugriff (PDF)

Results of a Large Scale Neutron Spectrometry and Dosimetry Comparison Exercise at the Cadarache Moderator Assembly

Radiation protection dosimetry, 1997-04, Vol.70 (1-4), p.313-322

1997

Volltextzugriff (PDF)

Response of Neutron Dosemeters in Radiation Protection Environments: An Investigation of Techniques to Improve Estimates of Dose Equivalent

Radiation protection dosimetry, 1997-04, Vol.70 (1-4), p.255-260

1997

Volltextzugriff (PDF)

A Performance Test of UK Personal Dosimetry Services for Fast Neutrons

Radiation protection dosimetry, 1993-08, Vol.48 (4), p.333-340

1993

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity

Provision of Organ at Risk Contouring Guidance in UK Radiotherapy Clinical Trials

8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group

1573 poster A DOSIMETRY COMPARISON OF FORWARD- AND INVERSE-PLANNED IMRT FOR PROSTATE CANCER IN THE CHHIP TRIAL

1575 poster A SURVEY OF THE BENEFITS TO RT PROCESSES AND TECHNIQUES OF PARTICIPATING IN THE CHHIP TRIAL

PO-0877 STREAMLINING UK IMRT CREDENTIALING: IMRT PLAN COMPLEXITY HIERARCHY

OC-0154: IGRT for prostate cancer ñ results from the CHHiP IGRT phase II sub-study

PO-1800: Successful Implementation of Treatment Planning Trial QA for the PIVOTALboost Trial

395 poster A REVIEW OF IMRT CREDENTIALING FOR CLINICAL TRIALS IN THE UK

OC-0421 Development and QA of IGRT procedures for node-positive prostate cancer patients in the PEARLS trial

A Comparison of Treatment Planning Techniques Used in Two Randomised UK External Beam Radiotherapy Trials for Localised Prostate Cancer

Variability Analysis of Clinical Target Volume Outlining for Prostate Stereotactic Body Radiotherapy within the Multicentre PACE Trial

1577 poster A UK-WIDE QUALITY ASSURANCE PROGRAMME FOR AN IMAGE-GUIDED RADIOTHERAPY PROSTATE TRIAL

PH-0602: Dosimetric impact of central OAR review on rectal and bladder constraint attainment in PACE-B trial

PD-0758 Fraction Size Sensitivity (α/β ratios) For Late Genitourinary Toxicities After Prostate EBRT

5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated External Beam Radiotherapy for Localized Prostate Cancer

PO-1348: Can reference data for TPS beam parameters be used to create a good quality dose calculation model?

OC-0289 Comparison of side effects at 2 years in the randomised PACE-B trial (SBRT vs standard radiotherapy)

OC-0421: Consistency of organs at risk delineation guidance in UK radiotherapy clinical trials

Patient Reported Acute Toxicity in PACE-B, an International Phase III Randomised Controlled Trial Comparing Stereotactic Body Radiotherapy to Conventionally Fractionated or Moderately Hypofractionated Radiotherapy (CFMHRT) for Localised Prostate Cancer

A Database of Neutron Spectra, Instrument Response Functions, and Dosimetric Conversion Factors for Radiation Protection Applications

Results of a Large Scale Neutron Spectrometry and Dosimetry Comparison Exercise at the Cadarache Moderator Assembly

Response of Neutron Dosemeters in Radiation Protection Environments: An Investigation of Techniques to Improve Estimates of Dose Equivalent

A Performance Test of UK Personal Dosimetry Services for Fast Neutrons

Suchergebnisse filtern